Cargando…
Correction: Yan, L., et al. Combined Taurine, Epigallocatechin Gallate and Genistein Therapy Reduces HSC-T6 Cell Proliferation and Modulates the Expression of Fibrogenic Factors. Int. J. Mol. Sci. 2013, 14, 20543–20554
Autores principales: | Li, Yan, Luo, Ying, Zhang, Xuerong, Lin, Xing, He, Min, Liao, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956543/ https://www.ncbi.nlm.nih.gov/pubmed/33653018 http://dx.doi.org/10.3390/ijms22052343 |
Ejemplares similares
-
Combined Taurine, Epigallocatechin Gallate and Genistein Therapy Reduces HSC-T6 Cell Proliferation and Modulates the Expression of Fibrogenic Factors
por: Li, Yan, et al.
Publicado: (2013) -
Anti-fibrosis activity of combination therapy with epigallocatechin gallate, taurine and genistein by regulating glycolysis, gluconeogenesis, and ribosomal and lysosomal signaling pathways in HSC-T6 cells
por: Li, Yan, et al.
Publicado: (2018) -
Correction: Sharov et al. Computational Analysis of Molnupiravir. Int. J. Mol. Sci. 2022, 23, 1508
por: Sharov, Artem V., et al.
Publicado: (2022) -
Inhibition Mechanisms of (−)-Epigallocatechin-3-gallate
and Genistein on Amyloid-beta 42 Peptide of Alzheimer’s Disease
via Molecular Simulations
por: Fang, Mei, et al.
Publicado: (2022) -
Addendum: Pesce et al. Irisin and Autophagy: First Update. Int. J. Mol. Sci. 2020, 21, 7587
por: Pesce, Mirko, et al.
Publicado: (2021)